66 related articles for article (PubMed ID: 28235765)
1. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.
Tsukamoto H; Fujieda K; Hirayama M; Ikeda T; Yuno A; Matsumura K; Fukuma D; Araki K; Mizuta H; Nakayama H; Senju S; Nishimura Y
Cancer Res; 2017 May; 77(9):2279-2291. PubMed ID: 28235765
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.
Liu M; Tong Z; Ding C; Luo F; Wu S; Wu C; Albeituni S; He L; Hu X; Tieri D; Rouchka EC; Hamada M; Takahashi S; Gibb AA; Kloecker G; Zhang HG; Bousamra M; Hill BG; Zhang X; Yan J
J Clin Invest; 2020 Apr; 130(4):2081-2096. PubMed ID: 31945018
[TBL] [Abstract][Full Text] [Related]
3. c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4
Gabryšová L; Alvarez-Martinez M; Luisier R; Cox LS; Sodenkamp J; Hosking C; Pérez-Mazliah D; Whicher C; Kannan Y; Potempa K; Wu X; Bhaw L; Wende H; Sieweke MH; Elgar G; Wilson M; Briscoe J; Metzis V; Langhorne J; Luscombe NM; O'Garra A
Nat Immunol; 2018 May; 19(5):497-507. PubMed ID: 29662170
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Specific Loss of p53 Leads to a Modulation of Myeloid and T Cell Responses.
Blagih J; Zani F; Chakravarty P; Hennequart M; Pilley S; Hobor S; Hock AK; Walton JB; Morton JP; Gronroos E; Mason S; Yang M; McNeish I; Swanton C; Blyth K; Vousden KH
Cell Rep; 2020 Jan; 30(2):481-496.e6. PubMed ID: 31940491
[TBL] [Abstract][Full Text] [Related]
5. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.
Pushalkar S; Hundeyin M; Daley D; Zambirinis CP; Kurz E; Mishra A; Mohan N; Aykut B; Usyk M; Torres LE; Werba G; Zhang K; Guo Y; Li Q; Akkad N; Lall S; Wadowski B; Gutierrez J; Kochen Rossi JA; Herzog JW; Diskin B; Torres-Hernandez A; Leinwand J; Wang W; Taunk PS; Savadkar S; Janal M; Saxena A; Li X; Cohen D; Sartor RB; Saxena D; Miller G
Cancer Discov; 2018 Apr; 8(4):403-416. PubMed ID: 29567829
[TBL] [Abstract][Full Text] [Related]
6. ATG5-regulated CCL2/MCP-1 production in myeloid cells selectively modulates anti-malarial CD4
Gao Y; Chen S; Jiao S; Fan Y; Li X; Tan N; Fang J; Xu L; Huang Y; Zhao J; Guo S; Liu T; Xu W
Autophagy; 2024 Feb; ():1-20. PubMed ID: 38368631
[TBL] [Abstract][Full Text] [Related]
7. A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity.
Rosa M; Chignon A; Li Z; Boulanger MC; Arsenault BJ; Bossé Y; Thériault S; Mathieu P
NPJ Genom Med; 2019; 4():23. PubMed ID: 31552141
[TBL] [Abstract][Full Text] [Related]
8. IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.
Wang L; Miyahira AK; Simons DL; Lu X; Chang AY; Wang C; Suni MA; Maino VC; Dirbas FM; Yim J; Waisman J; Lee PP
Cancer Res; 2017 Mar; 77(5):1119-1126. PubMed ID: 27879265
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-cell differentiation redefined in cancer.
Wynn TA
Nat Immunol; 2013 Mar; 14(3):197-9. PubMed ID: 23416669
[TBL] [Abstract][Full Text] [Related]
10. Network analyses: Inhibition of androgen receptor signaling reduces inflammation in the lung through AR-MAF-IL6 signaling axes.
Wang AR; Baschnagel AM; Ni Z; Brennan SR; Newton HK; Buehler D; Kendziorski C; Kimple RJ; Iyer G
Genes Dis; 2024 May; 11(3):101072. PubMed ID: 38292196
[No Abstract] [Full Text] [Related]
11. Exhaustion-associated regulatory regions in CD8
Mognol GP; Spreafico R; Wong V; Scott-Browne JP; Togher S; Hoffmann A; Hogan PG; Rao A; Trifari S
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2776-E2785. PubMed ID: 28283662
[TBL] [Abstract][Full Text] [Related]
12. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
Kamphorst AO; Wieland A; Nasti T; Yang S; Zhang R; Barber DL; Konieczny BT; Daugherty CZ; Koenig L; Yu K; Sica GL; Sharpe AH; Freeman GJ; Blazar BR; Turka LA; Owonikoko TK; Pillai RN; Ramalingam SS; Araki K; Ahmed R
Science; 2017 Mar; 355(6332):1423-1427. PubMed ID: 28280249
[TBL] [Abstract][Full Text] [Related]
13. Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.
Huber V; Camisaschi C; Berzi A; Ferro S; Lugini L; Triulzi T; Tuccitto A; Tagliabue E; Castelli C; Rivoltini L
Semin Cancer Biol; 2017 Apr; 43():74-89. PubMed ID: 28267587
[TBL] [Abstract][Full Text] [Related]
14. Human regulatory B cells in health and disease: therapeutic potential.
Mauri C; Menon M
J Clin Invest; 2017 Mar; 127(3):772-779. PubMed ID: 28248202
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy.
Robinson R; Srinivasan M; Shanmugam A; Ward A; Ganapathy V; Bloom J; Sharma A; Sharma S
Redox Biol; 2020 Jul; 34():101574. PubMed ID: 32422539
[TBL] [Abstract][Full Text] [Related]
16. Frontline Science: Proliferation of Ly6C
Dixit A; Bottek J; Beerlage AL; Schuettpelz J; Thiebes S; Brenzel A; Garbers C; Rose-John S; Mittrücker HW; Squire A; Engel DR
J Leukoc Biol; 2018 Jan; 103(1):13-22. PubMed ID: 28882904
[TBL] [Abstract][Full Text] [Related]
17. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
[TBL] [Abstract][Full Text] [Related]
18. The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells.
Na H; Im KI; Kim N; Lee J; Gil S; Min GJ; Cho SG
iScience; 2024 May; 27(5):109783. PubMed ID: 38726369
[TBL] [Abstract][Full Text] [Related]
19. R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice.
Chrysostomou SE; Eder S; Pototschnig I; Mayer AL; Derler M; Mussbacher M; Schauer S; Zhang D; Yan D; Liu G; Hoefler G; Weichhart T; Vesely PW; Zhang L; Schweiger M
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):562-574. PubMed ID: 38302863
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies.
Park EJ; Lee CW
Exp Mol Med; 2024 Feb; 56(1):100-109. PubMed ID: 38182653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
